XML 33 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (11,395,000) $ (17,506,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation, Total 293,000 206,000
Amortization of debt discount and issuance costs 1,160,000 2,372,000
Amortization of right-of-use asset 12,000 15,000
Interest expense added to loan principal 0 4,209,000
Interest expense added to lease liability 913,000 806,000
Loss on equity method investments 169,000 569,000
Compensation charge for stock and share option awards 856,000 3,440,000
Unrealized (gain) loss on warrant derivative liabilities 0 (573,000)
Changes in operating assets and liabilities:    
Accounts receivable 116,000 (11,000)
Prepaid expenses and other current assets (219,000) (544,000)
Other assets (242,000) 177,000
Accounts payable 216,000 (154,000)
Lease liabilities (172,000) (175,000)
Other accrued liabilities 743,000 1,170,000
Net cash used in operating activities (7,550,000) (5,999,000)
Cash flows from investing activities:    
Additions to property, plant and equipment and water programs (1,748,000) (20,177,000)
Contributions to equity-method investments (100,000) (259,000)
Net cash used in investing activities (1,848,000) (20,436,000)
Cash flows from financing activities:    
Net proceeds from issuance of stock 11,741,000 30,354,000
Proceeds from the issuance of warrants 0 4,000
Dividend payments (2,553,000) 0
Principal payments on long-term debt (69,000) (27,000)
Net cash provided by financing activities 9,119,000 30,331,000
Net (decrease) increase in cash, cash equivalents and restricted cash (279,000) 3,896,000
Cash, cash equivalents and restricted cash, beginning of period 19,856,000 7,424,000
Cash, cash equivalents and restricted cash, end of period $ 19,577,000 $ 11,320,000